Effects of diabetes compensation by various classes of antihyperglycemic agents on endovascular intervention outcomes in patients with type 2 diabetes mellitus
Introduction of drug-eluting stents for percutaneous coronary interventions opened novel options for treating coronary heart disease (CHD) in patients with diabetes mellitus. However, mortality and myocardial infarction rates are still higher among diabetes patients. They also require repeated revas...
Saved in:
Main Authors: | Marina Sergeevna Michurova, Irina Vladimirovna Kononenko, Olga Mikhailovna Smirnova, Victor Yur'evich Kalashnikov |
---|---|
Format: | article |
Language: | EN RU |
Published: |
Endocrinology Research Centre
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/e58e32fb4e6c43c8a05590da5d4e18bb |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mobilization of endothelial progenitor cells after endovascular interventions in patients with type 2 diabetes mellitus
by: Marina Sergeevna Michurova, et al.
Published: (2014) -
Endothelial progenitor cells and vascular endothelial growth factor after endovascular interventions in patients with type 2 diabetes
by: Marina Sergeevna Michurova, et al.
Published: (2017) -
Antihyperglycemic therapy in patients with type 2 diabetes mellitus and ischaemic heart disease: management during acute period of myocardial infarction and interventional procedures
by: Olga Mikhailovna Smirnova, et al.
Published: (2012) -
Long-term comparison of everolimus- vs.
novolimus-eluting bioresorbable vascular scaffolds
in real world patients
by: Beytullah Cakal, et al.
Published: (2020) -
Myocardial revascularization in patients with type 2 diabetes mellitus: An overview of modern techniques
by: Elena Zelikovna Golukhova, et al.
Published: (2016)